Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LIMOR (Laboratory for Investigative Medical Oncology Research) is a specialized clinical research laboratory based at the Amsterdam UMC in the Netherlands. The laboratory provides comprehensive bioanalytical services, including pharmacokinetics (PK), pharmacodynamics (PD), and biomarker analysis to support Phase I through Phase III clinical trials. Operating under GCLP (Good Clinical Laboratory Practice) standards, LIMOR collaborates extensively with global pharmaceutical and biotechnology companies to evaluate novel oncology therapeutics. Its expertise spans small molecules and biologics, with a particular focus on intracellular drug metabolism and mechanism-of-action studies. By bridging academic research and clinical application, LIMOR serves as a critical partner for global pharmaceutical and biotechnology companies. The facility is integrated within the Cancer Center Amsterdam, leveraging deep academic expertise to provide high-quality data for regulatory submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LIMOR laboratory.